Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study
| Autor: | Giannotta, Juri Alessandro 1, Artoni, Andrea 1, Mancini, Ilaria 1, Agosti, Pasquale 1, 2, Carpenedo, Monica 3, Truma, Addolorata 2, Miri, Syna 1, Ferrari, Barbara 1, De Leo, Pasqualina 1, Salutari, Prassede 4, Mancini, Giorgia 5, Molteni, Alfredo 6, Rinaldi, Ermina 7, Bocchia, Monica 8, Napolitano, Mariasanta 9, 10, Prezioso, Lucia 11, Cuccaro, Annarosa 12, Scarpa, Elisabetta 13, Condorelli, Annalisa 14, Grimaldi, Daniele 15, Massaia, Massimo 15, Peyvandi, Flora 1, 2, ∗ |
|---|---|
| Zdroj: | In Journal of Thrombosis and Haemostasis February 2025 23(2):704-716 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|